Given the overall absence of PD-1 and PD-L1 immunoreactive tumor cells and 4/19 ACC tumor samples expressing PD-L1 (<5% (1+) in immune cells, it is less likely that the PD-1/PD-L1 immune escape pathway plays an important role in pediatric ACC. The gene discussed is PDCD1; the disease is neoplasm.